Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:


Potent antimalarial drugs with validated activities

Drug resistance in tropical diseases such as malaria requires constant improvement and development of new drugs. To find potential candidates, generative machine learning methods that can search for novel bioactive molecules can be employed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Architecture of the junction-tree variational autoencoder (JT-VAE) model.


  1. Godinez, W. J. et al. Nat. Mach. Intell. (2022).

  2. Winkler, D. A. Front. Chem. 9, 39 (2021).

    Article  Google Scholar 

  3. Weininger, D. J. Chem. Inf. Comp. Sci. 28, 31–36 (1988).

    Article  Google Scholar 

  4. Jin, W., Barzilay, R. & Jaakkola, T. in Proc. of the 35th International Conference on Machine Learning 80 (eds Dy, J. & Krause, A.) 2323–2332 (PMLR, 2018).

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to David A. Winkler.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Winkler, D.A. Potent antimalarial drugs with validated activities. Nat Mach Intell 4, 102–103 (2022).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing